Moderna’s RSV Vaccine Reduces Risk of Respiratory Diseases, Study Finds

Health The company says the experimental shot was 83.7% effective against lower-respiratory diseases caused by RSV

Why Biotech Is Poised for a Recovery This Year

Market heard on the street Pharma and biotech stocks moved in opposite directions last year, but…

When Executives Stop Selling Stock, a Big Deal Might Be Ahead

Market deal Stagnation in insider selling may be a clue for investors, past bids show

FDA Commissioner Denies Wrongdoing in Approval Process for Biogen Alzheimer’s Drug Aduhelm

Robert Calif acknowledged that the agency made mistakes when it failed to properly document interactions with…